// App-Quantinova.ai

SA-OR23 : Activation of AMP-Activated Protein Kinase In Vivo Leads to a Polycystic Kidney Disease

Researchers

Presenter

  • Wilson Laura

Principal Investigators

  • Carling David

Medical Centers

  • University College London, Institute of Child Health, London, London, United Kingdom

  • MRC London Institute of Medical Sciences London Greater London United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

Disease

  • Polycystic kidney disease

Biomarkers

  • AMP-activated protein kinase

  • Nucleoside diphosphate kinase A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved